When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRTX - Cortexyme advancing study of lead drug in Alzheimer's
Cortexyme Inc.
Cortexyme (NASDAQ:CRTX)announces that it has enrolled 500 subjects in its Phase 2/3 GAIN study evaluating lead candidate atuzaginstat (COR388) in patients with mild-to-moderate Alzheimer's disease.
More news on: Cortexyme, Inc., Healthcare stocks news,